[Federal Register Volume 70, Number 225 (Wednesday, November 23, 2005)]
[Notices]
[Pages 70860-70861]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23155]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the Substance Abuse and Mental Health Services Administration 
(SAMHSA) Drug Testing Advisory Board on December 13-14, 2005.
    A portion of the meeting will be open and will include a roll call, 
general announcements, a Department of Health and Human Services drug 
testing program update, a Department of Transportation drug testing 
program update, and a Nuclear Regulatory Commission drug testing 
program update.
    Attendance by the public will be limited to space available. Public 
comments are welcome. Please communicate with the individual listed 
below as contact to make arrangements to comment or to request special 
accommodations for persons with disabilities.
    The Board will also meet to develop the final revisions to the 
proposed Mandatory Guidelines for Federal Workplace Drug Testing 
Programs that were published in the Federal Register on April 13, 2004 
(69 FR 19673) and to discuss Federal agency specimen results, medical 
review officer interpretations, laboratory inspection issues, and 
analytical instrumentation issues. This meeting will be conducted in 
closed session since discussing these issues in open session will 
significantly frustrate the Department's ability to develop the 
revisions to the Mandatory Guidelines or to disclose information of a 
personal nature where disclosure would constitute an unwarranted 
invasion of personal privacy. The HHS Office of General Counsel made 
the determination that such matters are protected by exemptions (6) and 
9(B) of section 552b(c) of title 5 U.S.C. and therefore may be closed 
to the public.
    To facilitate entering the building for the open session, public 
attendees are

[[Page 70861]]

required to contact Mrs. Giselle Hersh, Division of Workplace Programs, 
1 Choke Cherry Road, Room 2-1042, Rockville, MD 20857, 240-276-2605 
(telephone) or by e-mail to [email protected].
    Substantive program information and a roster of Board members may 
be obtained by accessing the SAMHSA workplace Web site (http://workplace.samhsa.gov) or communicating with the contact whose name and 
telephone number are listed below. The transcript for the open session 
will be available on the SAMHSA workplace Web site as soon as possible 
after the meeting.
    Committee Name: Substance Abuse and Mental Health Services 
Administration Drug Testing Advisory Board.
    Meeting Date: December 13-14, 2005.
    Place: SAMHSA Building, Sugarloaf Conference Room, 1 Choke Cherry 
Road, Rockville, Maryland 20850.
    Type: Open: December 13, 2005; 8:30 a.m.-10:30 a.m.
    Closed: December 13, 2005; 10:30 a.m.-4:30 p.m.
    Closed: December 14, 2005; 8:30 a.m.-Noon.
    Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke Cherry 
Road, Room 2-1033, Rockville, Maryland 20857, 240-276-2600 (telephone) 
and 240-276-2610 (fax), e-mail: [email protected].

    Dated: November 17, 2005.
Robert E. Stephenson,
Acting Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. 05-23155 Filed 11-22-05; 8:45 am]
BILLING CODE 4162-20-P